Pihlajalinna’s Q1 result was strong and slightly above our estimates. The positive earnings development was again based on clearly improved profitability in the private clinic network. We raised our estimates in line with the earnings overshoot of Q1. We still find the company’s return/risk ratio good despite the elevated political risks.